How does the CyberKnife System work?

The CyberKnife system uses image guidance technology and computer controlled robotics to continuously track, detect and correct for tumor and patient movement throughout the treatment allowing for its extreme precision. the CyberKnife System does not require head or body frames to stabilize patient movement, vastly increasing the system's flexibility.

What makes the CyberKnife unique?

1. Total Clincal Accuracy - the CyberKnife system has proben to be the most accurate, real-time, image-guided robotic radiosurgery system in the world. CyberKnife robotic radiosurgery is so precise, radiation beams can conform to small, complex-shaped tumors while minimizing damage to surrounding healthy tissue.
2. 100% Frameless - the combination of the image-guidance system and the multi-jointed robotic arm allows the system to compensate for patient movement, sparing patients from the pain and inconvenience associated with the conventional head frame that is fixed to the patient's skull. This systems also allows CyberKnife to treat tumors in organs that move such as the lung, liver, kidneys, and pancreas.
3. Painless Surgery - the CyberKnife System allows patients to be treated in a unique radiosurgery suite where painless "surgery" is performed with no incisions, no blood, no anesthesia, and no recovery time.
4. Better Quality of Life, During & After Treatment - the simple outpatient CyberKnife procedure allows patients to undergo their treatment and immediately resume normal activities.

Is the CyberKnife clinically proven?

The CyberKnife System utilizes radiation technology that has been proven for over 30 years. Additionally, over 30,000 patients have received CyberKnife treatments worldwide.

Is the CyberKnife cleared by the FDA?

The CyberKnife System received clearance from the FDA in July 1999 for the treatment of head and neck tumors. In October 2001, the FDA extended its clearance to include the treatment of tumors and other conditions anywhere in the body.

The CyberKnife received FDA clearance in April 2002 to market an additional product enhancement that enables the CyberKnife System to continuously track, detect, and correct for tumor and patient movement throughout the treatment. A CE Mark for the CyberKnife System enabling distribution in the European community was received in September 2002.

What types of tumors can be treated?

The CyberKnife System is cleared by the FDA to treat tumors anywehre in the body. Consult with your physician to see if CyberKnife treatment is right for you.

Who will be involved during my treatment?

A highly experienced clinical team of doctors will be utilized to evaluate and make treatment recommendations. Team members may include your surgeon, radiation oncologist, and  medical physicist.